Pace® Life Sciences has been recognized by PharmaSource as a Top CDMO in the United States
The United States is global powerhouse in pharmaceutical contract development and manufacturing, home to some of the world’s most advanced […]
Life Sciences
Pace® Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities to Support Increasing Demand for Sterile Injectables
Company reopens state-of-the-art isolated vial filling line at Aseptic Fill-Finish Center of Excellence MINNEAPOLIS, MN – August 12, 2025 –
Pace® Life Sciences Achieves Fourth Consecutive Positive FDA Inspection, Reinforcing Quality Commitment
Research Triangle Park, NC site received a positive FDA Review, marking a milestone as all company Analytical Outsourcing sites have
Pace® Life Sciences Hosts Grand Opening of its Center of Excellence for Aseptic Fill-Finish Services in Salem, NH
July 16 open house highlights expanded sterile filling contract manufacturing capabilities for small and large molecules Minneapolis, MN – July
Pace® Life Sciences Announces Successful Pre-Approval Inspection from US FDA in Lebanon, NJ
Company confirms high standards for data integrity and quality systems MINNEAPOLIS, MN, May 20, 2025 Pace® Life Sciences, a U.S.-based full-service
Future role of Pace® Life Sciences in supporting biopharmaceutical development and manufacturing coast-to-coast – Dean Bornilla, Vice President.
With a growing network of locations across major US pharmaceutical hubs, Pace® aims to enhance customer experience through consistent quality
Nitrosamine Testing
Experienced Nitrosamine Impurity Testing Evaluate the potential for nitrosamine impurities in your drug product with our expert testing services. Nitrosamines
Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Commitment to Sustainability
Company stands out in Ethics, Environment, and Labor and Human Rights focus areas for 2024 Minneapolis, MN – April 1,
Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences
The modern therapeutic landscape is defined by an ever-growing portfolio of complex drug products – from biologics and gene therapies
Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025
Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more. Minneapolis, MN – January 10, 2025 –